Search company, investor...


Founded Year



Bridge | Alive

Total Raised


Last Raised

$2.5M | 1 yr ago

About Himedi

Himedi specializes in providing concierge medical tourism services for international patients. The company helps patients with medical appointments, flights, hotels, limousine service, tour/shopping info, VIP hospitality, operating medical hotlines and issuing medical visas, and more.

Headquarters Location

69, Noksapyeong-daero 32-gil, Yongsan-gu 1F

Seoul, 04390,

South Korea

+82 (70)-8146-8986

Missing: Himedi's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Himedi's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Himedi

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Himedi is included in 1 Expert Collection, including Digital Health.


Digital Health

12,650 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

Latest Himedi News

Himedi’s platform draws over 10,000 foreign subscribers

Jan 5, 2022

Himedi’s platform draws over 10,000 foreign subscribers 바로가기 기자명 Lee Han-soo 닫기 Himedi, a company that has developed a platform to attract foreign patients, said that foreign subscribers had exceeded 10,000. Himedi's platform for attracting foreign patients has surpassed 10,000 subscribers. The company introduced medical concierge services, including interpretation, accommodation, and transportation, for patients from the Middle East in 2011. In August 2020, it also launched the platform to lure foreign patients. Most subscribers are seriously ill patients from Mongolia, the Middle East, and Kazakhstan. The number of subscribers had increased rapidly since June last year when the company launched non-face-to-face medical services for patients unable to visit Korea due to Covid-19. The number of non-face-to-face requests has surpassed 3,700 in six months of service, with the cumulative number of requests reaching 4,700. As the platform targets foreigners with severe diseases difficult to treat in their countries, many patients who received non-face-to-face treatment come to Korea later to get face-to-face treatment, the company said. Last year, the average treatment cost per patient who entered Korea after non-face-to-face treatment through Himedi stood at 17 million won ($14,183). The highest was 100 million won for a patient who received rectal cancer surgery, while the lowest was 10 million won for a brain tumor surgery. The most frequently requested non-face-to-face treatment were female diseases such as infertility, uterine fibroids, gynecological cancer, followed by orthopedic diseases, such as the spine and joints, and internal medical diseases, such as cancer and tumors, according to Himedi. "Himedi's customers are foreign patients who are severely ill, and most of them require Korean medical services," Himedi co-CEO Seo Don-gyo said. "It will become a platform for drawing foreign patients, which provides a good solution not only to patients who have difficulty receiving quality treatment in their home country but also to Korean hospitals whose profits have deteriorated due to Covid-19." The company plans to expand its services to Southeast Asia and English-speaking countries, where demand is high for plastic surgery, beauty, and severe diseases, to increase Korea's global market share to attract foreign patients worth 100 trillion won annually.

Himedi Frequently Asked Questions (FAQ)

  • When was Himedi founded?

    Himedi was founded in 2011.

  • Where is Himedi's headquarters?

    Himedi's headquarters is located at 69, Noksapyeong-daero 32-gil, Yongsan-gu, Seoul.

  • What is Himedi's latest funding round?

    Himedi's latest funding round is Bridge.

  • How much did Himedi raise?

    Himedi raised a total of $9.21M.

  • Who are the investors of Himedi?

    Investors of Himedi include White Star Capital, TBT Partners, Murex Partners, Solidus Investment and Lighthouse Combined Investment.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.